Tyrosine Kinase Inhibitor Can Induced a Continuous Improving Effect on Idiopathic Pulmonary Fibrosis
The continuous effect of tyrosine kinase inhibitor on idiopathic pulmonary was newly found and the effect can last about two years to slow the progression of idiopathic pulmonary (IPF), which […]